Epredia made its E1000 Dx digital pathology solution and SlideMate TSP debut in China, bringing new capabilities to pathology laboratories across the region.
Published
Signal category
Products & Services
Quote
“Epredia E1000 Dx digital pathology solution and SlideMate TSP made their debut in China, bringing new capabilities to pathology laboratories across the region.”
— Epredia team
Company
Epredia
Improving lives by enhancing precision cancer diagnostics
- Industry
- Biotechnology Research
- Location
- Portsmouth, US
- Company size
- 755 employees
Every second of every hour of every day, 44 of our products are employed in the battle against cancer. Customers put their trust in Epredia over a billion times every year. Epredia was established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific. Powered by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, Epredia has a wide breadth of solutions that have and will continue to transform the anatomical pathology market. Today, we’re a global precision cancer diagnostics company working to improve patient outcomes by providing groundbreaking technologies. Since our humble beginnings in 1937, every product developed has been impacted by generations of employees who are committed to improving lives by enabling pathologists through enhancing precision cancer diagnostics. Find out how you can improve lives while advancing your career at #Epredia by visiting epredia.com/careers. #WhatWeDoMatters
Founded 2019